Business Context and Reporting Period
This Form 8-K Current Report was filed by enVVeno Medical Corporation (formerly Hancock Jaffe Laboratories, Inc.) on September 29, 2021. The report documents a corporate name change effective October 1, 2021, at 12:01 a.m. Eastern time. The company is incorporated in Delaware and its principal executive offices are located in Irvine, California.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a corporate event and does not contain financial statements or performance metrics.
Material Changes
- Corporate Name: Changed from "Hancock Jaffe Laboratories, Inc." to "enVVeno Medical Corporation."
- Trading Symbols: Common stock now trades under the symbol "NVNO" and warrants under "NVNOW" on The NASDAQ Stock Market LLC.
- Legal Action: A Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation was filed with the Secretary of State of Delaware on September 29, 2021.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the announcement of the name change and the associated filing of the Certificate of Amendment.
Key Facts for Investor Verification
- Verify the new ticker symbols "NVNO" (Common Stock) and "NVNOW" (Warrants) on The NASDAQ Stock Market LLC.
- Confirm the effective date of the name change as October 1, 2021.
- Review the attached Exhibit 3.1 (Certificate of Amendment) for specific details regarding the amendment to the Certificate of Incorporation.
- Note that the company identifies as an emerging growth company.